We are live on ! Find out more
AMED

Amedisys
AMED

Delisted

AMED was delisted on the 14th of August, 2025.

Back to rankings

288 hedge funds and large institutions have $2.85B invested in Amedisys in 2024 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 93 increasing their positions, 104 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 32

18% more funds holding in top 10

Funds holding in top 10: 11 → 13 (+2)

2% more funds holding

Funds holding: 283 → 288 (+5)

0.07% more ownership

Funds ownership: 94.92% → 94.99% (+0.07%)

0% less capital invested

Capital invested by funds: $2.86B → $2.85B (-$5.8M)

11% less repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 104

82% less call options, than puts

Call options by funds: $17.1M | Put options by funds: $94.3M

Holders
288
Holders Change
+5
Holders Change %
+1.77%
% of All Funds
4.16%
Holding in Top 10
13
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+18.18%
% of All Funds
0.19%
New
42
Increased
93
Reduced
104
Closed
32
Calls
$17.1M
Puts
$94.3M
Net Calls
-$77.2M
Net Calls Change
-$8.21M

Top Buyers

1
Goldman Sachs
Goldman Sachs
New York
+$96.9M
2
FCM
Farallon Capital Management
California
+$27.9M
3
AllianceBernstein
AllianceBernstein
Tennessee
+$19.4M
4
LP
LMR Partners
United Kingdom
+$18.5M
5
SGCM
Sand Grove Capital Management
United Kingdom
+$17.5M

Top Sellers

1
Millennium Management
Millennium Management
New York
-$32.3M
2
PWAM
Park West Asset Management
California
-$29.6M
3
WP
Woodline Partners
California
-$19.5M
4
MAM
Melqart Asset Management
United Kingdom
-$18.9M
5
Boston Partners
Boston Partners
Massachusetts
-$18.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
ATPW
251
Ashton Thomas Private Wealth
Arizona
$4.68K +$4.73K +51 New
Mitsubishi UFJ Asset Management
252
Mitsubishi UFJ Asset Management
Japan
$4.59K – – –
CC
253
Cypress Capital
Tennessee
$4.59K +$4.64K +50 New
VCM
254
Versant Capital Management
Arizona
$4.41K +$2.32K +25 +109%
BTI
255
Blue Trust Inc
Georgia
$4.33K +$4.36K +47 New
QC
256
Quent Capital
New York
$4.32K +$2.69K +29 +161%
CAL
257
Capital Advisors Ltd
Ohio
$4K – – –
LFA
258
LGT Financial Advisors
Texas
$3.95K -$4.83K -52 -55%
GRP
259
Global Retirement Partners
California
$3.49K +$1.02K +11 +41%
PWMG
260
Prestige Wealth Management Group
New Jersey
$3.4K – – –
EWA
261
EverSource Wealth Advisors
Alabama
$3.24K +$2.6K +28 +560%
PFBT
262
Parkside Financial Bank & Trust
Missouri
$2.94K -$33.3K -359 -92%
PTC
263
Private Trust Company
Ohio
$2.94K – – –
HNB
264
Huntington National Bank
Ohio
$2.57K +$2.5K +27 +2,700%
FRA
265
Front Row Advisors
California
$2.48K – – –
CPG
266
Cornerstone Planning Group
New Jersey
$2.05K -$6.22K -67 -76%
W
267
WealthCollab
Washington
$1.75K – – –
UB
268
UMB Bank
Missouri
$1.74K +$835 +9 +90%
MG
269
Mather Group
Illinois
$1.66K +$186 +2 +13%
Fuller & Thaler Asset Management
270
Fuller & Thaler Asset Management
California
$1.47K – – –
FMII
271
Farmers & Merchants Investments Inc
Nebraska
$1.38K – – –
Jones Financial Companies
272
Jones Financial Companies
Missouri
$1.38K +$1.39K +15 New
SJIM
273
St. Johns Investment Management
Florida
$1.28K – – –
CTC
274
Central Trust Company
Missouri
$1.19K -$1.02K -11 -46%
NA
275
NewEdge Advisors
Louisiana
$1.19K – – –
9 10
11
12 13

AMED Hedge Fund Activity: Q2 2024 in Review

288 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q2 2024, worth a combined $2.85B — down 0.2% from $2.86B a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new AMED positions and 32 closed out — a net gain of 10 holders — while 93 added to existing stakes and 104 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $96.9M. The largest seller was Millennium Management, cutting an estimated $32.3M.

  • 288 institutional investors held Amedisys (AMED) as of Q2 2024, up from 283 in Q1 2024.
  • Funds reported $2.85B of Amedisys stock for Q2 2024, down 0.2% quarter-over-quarter.
  • 42 funds opened new Amedisys positions in Q2 2024 and 32 closed out, a net change of +10 holders.
  • The largest Amedisys buyer in Q2 2024 was Goldman Sachs, an estimated $96.9M added.
  • The largest Amedisys seller in Q2 2024 was Millennium Management, an estimated $32.3M sold.

Based on aggregated 13F filings for Q2 2024.